Evidence map›Paper›PMID 32995331›Full record

ArticleAvicenna journal of phytomedicine

Anticancer activity of

Fouad Mehraban, Mostafa Mostafazadeh, Hossein Sadeghi, Arsalan Azizi, Mehdi Akbartabar Toori, Bita Gramizadeh, Vahid Barati, Heibatollah Sadeghi

Open access · greenAbstract read
In one paragraph

Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Biomolecules · 2024
    Review
  3. Review
  4. Article
  5. International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Fouad MehrabanInstitute of Biochemistry and Biophysics (IBB), Tehran University, Tehran, Iran.
Mostafa MostafazadehDepartment of Biochemistry and Clinical Laboratories, Tabriz University of Medical Sciences, Tabriz, Iran.
Hossein SadeghiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Arsalan AziziDepartment of Pathology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.
Mehdi Akbartabar TooriSocial Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Bita GramizadehDepartment of Pathology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Vahid BaratiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Heibatollah SadeghiCellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.
Yasuj University of Medical Sciences · IRShiraz University of Medical Sciences · IRTabriz University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSome species of MATERIALS AND

methodsThe anti-tumor and antioxidant effects of AOE were evaluated against DMBA-induced breast carcinoma in rats using DPPH, FRAP and ABTS technique, respectively. Forty adult female Sprague-Dawley rats were randomly divided into four groups including the control group received a single dose of DMBA solvent orally, and groups II, III and IV received a single dose of DMBA (40 mg/kg) dissolved in olive oil. Groups I and II received normal saline and groups III and IV were treated with AOE orally (120 and 240 mg/kg respectively) for 60 consecutive days. Chemopreventive effects were assessed in terms of diameter and volume of tumors, expression levels of PCNA, and serum levels of CA15.3, p53, MDA, CAT, and calcium, and histopathological features.

resultsAOE contained a noticeable amount of phenolic and flavonoids compounds. This extract showed a potent antioxidant activity both

conclusionAccording to the data, AOE produced a significant chemopreventive activity in DMBA-induced breast tumors in rats, probably due to its antioxidant and its inhibitory effect on some tumorigenicity markers such as CA15.3, p53 and PCNA activity.

Indexed as

2-benzanthracene (DMBA)AntioxidantAstragalus ovinousBreast cancerDimethyl-1Rat

Identifiers

PMID32995331
PMCPMC7508319
OpenAlexW3089079402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.